These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35865945)

  • 1. Erectile Dysfunction: Key Role of Cavernous Smooth Muscle Cells.
    de Souza ILL; Ferreira EDS; Vasconcelos LHC; Cavalcante FA; da Silva BA
    Front Pharmacol; 2022; 13():895044. PubMed ID: 35865945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
    Ali ST
    Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New treatment options for erectile dysfunction in patients with diabetes mellitus.
    Basu A; Ryder RE
    Drugs; 2004; 64(23):2667-88. PubMed ID: 15537369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New treatment options for erectile dysfunction. Pharmacologic and nonpharmacologic options].
    Sperling H; Lümmen G; Schneider T; Rübben H
    Herz; 2003 Jun; 28(4):314-24. PubMed ID: 12825147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evoked cavernous activity.
    Yilmaz U; Soylu A; Ozcan C; Kutlu R; Güneş A
    J Urol; 2002 Jan; 167(1):188-91. PubMed ID: 11743302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy.
    Nehra A; Blute ML; Barrett DM; Moreland RB
    Int J Impot Res; 2002 Feb; 14 Suppl 1():S38-42. PubMed ID: 11850734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erectile dysfunction: from biochemical pharmacology to advances in medical therapy.
    Maggi M; Filippi S; Ledda F; Magini A; Forti G
    Eur J Endocrinol; 2000 Aug; 143(2):143-54. PubMed ID: 10913932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrergic-noradrenergic interaction in penile erection: a new insight into erectile dysfunction.
    Cellek S
    Drugs Today (Barc); 2000; 36(2-3):135-46. PubMed ID: 12879111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of icariin in combination with daily sildenafil on penile atrophy and erectile dysfunction in a rat model of bilateral cavernous nerves injury.
    Xu Y; Xin H; Wu Y; Guan R; Lei H; Fu X; Xin Z; Yang Y
    Andrology; 2017 May; 5(3):598-605. PubMed ID: 28296277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of phosphodiesterase 5 inhibition in erectile dysfunction.
    Rosen RC; Kostis JB
    Am J Cardiol; 2003 Nov; 92(9A):9M-18M. PubMed ID: 14609619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiology and pathophysiology of erection: consequences for present medical therapy of erectile dysfunction.
    Schultheiss D; Stief CG
    Andrologia; 1999; 31 Suppl 1():59-64. PubMed ID: 10643521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic AMP-specific and cyclic GMP-specific phosphodiesterase isoenzymes in human cavernous arteries--immunohistochemical distribution and functional significance.
    Waldkirch E; Uckert S; Yildirim H; Sohn M; Jonas U; Stief CG; Andersson KE; Hedlund P
    World J Urol; 2005 Dec; 23(6):405-10. PubMed ID: 16292559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction.
    Andersson KE
    Pharmacol Rev; 2011 Dec; 63(4):811-59. PubMed ID: 21880989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintenance of the contractile phenotype in corpus cavernosum smooth muscle cells by Myocardin gene therapy ameliorates erectile dysfunction in bilateral cavernous nerve injury rats.
    Zhang HB; Wang ZQ; Chen FZ; Ding W; Liu WB; Chen ZR; He SH; Wei AY
    Andrology; 2017 Jul; 5(4):798-806. PubMed ID: 28544569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nitroxidergic (nitrergic) nerve and erectile dysfunction].
    Ayajiki K; Toda N; Okamura T
    Nihon Yakurigaku Zasshi; 2002 Jan; 119(1):21-8. PubMed ID: 11862753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of sildenafil citrate in the treatment of male erectile dysfunction.
    Goldenberg MM
    Clin Ther; 1998; 20(6):1033-48. PubMed ID: 9916601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erectile physiological and pathophysiological pathways involved in erectile dysfunction.
    Andersson KE
    J Urol; 2003 Aug; 170(2 Pt 2):S6-13; discussion S13-4. PubMed ID: 12853766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacological profiles of sildenafil (VIAGRA) in the treatment of erectile dysfunction: efficacy and drug interaction with nitrate].
    Omote M
    Nihon Yakurigaku Zasshi; 1999 Oct; 114(4):213-8. PubMed ID: 10584234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physiology of erection].
    Giuliano F; Rampin O; Jardin A
    Rev Med Interne; 1997; 18 Suppl 1():3s-9s. PubMed ID: 9183454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of human growth hormone during different penile conditions in the cavernous and systemic blood of healthy men and patients with erectile dysfunction.
    Becker AJ; Uckert S; Stief CG; Scheller F; Knapp WH; Hartmann U; Brabant G; Jonas U
    Urology; 2002 Apr; 59(4):609-14. PubMed ID: 11927337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.